Menu Back toSession 8: Regulatory Convergence in Pandemic Situations

Latin America Regulatory Conference


Session 8: Regulatory Convergence in Pandemic Situations

Session Chair(s)

Roberta  Mele Mazza, RPh, RAC

Roberta Mele Mazza, RPh, RAC

  • Q&RA Manager, División Diagnóstica
  • Productos Roche , Argentina
Maria Cristina  Mota Pina, MBA

Maria Cristina Mota Pina, MBA

  • Director, Regulatory Policy and Intelligence -Japan, Emerging Markets, Australia
  • AbbVie, Inc., United States
“Regulatory convergence,” represents a process whereby the regulatory requirements across countries or regions become more similar or “aligned” over time. This session aims to provide an overview of “lessons learned” during a pandemic situation and share examples of good regulatory practices for medical devices and medicines in the Latin America the region.
Learning Objective :
  • Raise the awareness on different Convergence initiatives already existing and new initiatives for medical devices and medicines
  • Understand how Regulators are working towards regulatory convergence in pandemic situations for medical devices and medicines
  • Provide an industry perspective in how regulatory convergence initiatives supports availability of medical devices and medicines in pandemic situations

Speaker(s)

Agnès  Saint-Raymond, DrMed

Speaker

Agnès Saint-Raymond, DrMed

  • Head of Division International Affairs
  • European Medicines Agency, Netherlands
Rebecca  Lumsden, PhD

Regulatory Convergence in Pandemic Situations an Industry perspective

Rebecca Lumsden, PhD

  • Director, Regulatory Policy and Intelligence
  • Pfizer Inc, United Kingdom
Sandra  González

Regulatory Convergence in Pandemic Situations

Sandra González

  • Executive Secretary,Inter-American Coalition for Regulatory Convergence
  • Advanced Medical Technology Association (AdvaMed), United States
Steven  Bipes

Panelist

Steven Bipes

  • Vice President - Global Strategy and Analysis
  • Advanced Medical Technology Association (AdvaMed), United States

Contact us

Registration Questions?

Send Email
1.888.257.6457


On Demand Content Preview Webinar

Registration Pathways to Accelerate Regulatory Assessment of Innovative Medicines in Latin America
Register Today!